Home » Biotechnology » High Throughput Screening Market

High Throughput Screening Market By Technology Type (Cell Based Assays, Ultra High Throughput Screening, Lab-on-a-Chip, Bioinformatics, Label Free Technology), By Application (Target Identification, Primary & Secondary Screening, Toxicology Assessment, Others), By End User (Biotechnology & Pharmaceutical Industries, Academic & Government Research Institutes, Contract Research Organizations, Others) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Summary
Table Of Content

High throughput screening market to exhibit productive growth during the forecast period.

The global high-throughput screening (HTS) market is expanding rapidly, with a value of US$ 13.2 billion in 2017 and a projected value of US$ 24.4 billion by 2026. The increasing need for drug discovery in pharmaceuticals and biotechnology will enhance the overall expansion of the high-throughput screening market globally.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

New technology assessment in the field of cell-based assays is significant; the fluorometric imaging plate reader and cell-based assays will drive the market in developed nations. New automated platforms for ultra-high throughput screening will gain traction globally. Additionally, the adoption of advanced testing and detection platforms, utilization of 3D-based cultures, and better funding from research organizations or public sources will further spur revenue growth during the forecast period.

The easy affordability of novel automated platforms, the increasing need for new therapies, and rapid new product launches are factors driving the HTS market growth in developed countries. Nevertheless, the high cost of automated systems, lack of infrastructure, and economic issues associated with complex HTS and R&D are a few factors limiting the growth of the high throughput screening market globally.

Market Synopsis

Ultra-high throughput screening (uHTS) in drug discovery is expected to register higher growth by 2026.

High-throughput screening technologies are categorized into cell-based assays, ultra-high-throughput screening, lab-on-a-chip, bioinformatics, and label-free technology. The growing number of drug targets for primary and secondary screening, as well as research funding from the government, private sector, and research institutes, are boosting overall growth in developed countries.

Current trends show improvements in chemical libraries and advanced software, along with automation techniques with high standards and enhanced outcomes via screening procedures. The increasing need for newer treatments for a number of disease conditions is supporting new technology assessments in high-throughput screening.

Currently, drug discovery platforms with ultra-high throughput screening are well-defined by screening numbers. However, the high cost and low efficiency of advanced software for liquid handling systems, plate reader detection, and automated robotic arms have a negative impact on the market.

Drug discovery platforms to witness a significant CAGR

The high-throughput screening techniques are utilized in various application areas, such as target identification, primary and secondary screening, toxicology assessment, and others. Pharmaceutical and biotech companies have funded a wide scale of automated systems to increase the adoption of throughput screening across the early stages of drug discovery processes.

Maximum revenue share is being generated by the increased use of ultra-high-throughput screening and advanced robotic platforms. Additionally, noteworthy developments in specialized instrumentation, such as multi-mode microplate readers, will gain traction globally. HTS processes have evolved to carry out various procedures in an automated environment using a custom-engineered 3D imaging system.

For instance, in November 2018, NTRC (the Netherlands Translational Research Center) launched the first high-throughput screening assay for arginase-1 inhibitors at ENA2018. Other applications, such as automating target-based and complex phenotypic drug discovery, cytotoxicity detection, and advanced primary screening in cell-based assays, show promising opportunities during the forecast period.

Increasing applications in biotechnology and the pharmaceutical industry witness a significant CAGR.

High-throughput screening processes are utilized in various areas, with prime occupations in pharmaceuticals and biotechnology. Due to the numerous technology assessments taking place on drug discovery platforms, various small and medium-sized pharmaceutical and biotech companies are intensively focused on the development of novel molecules for numerous life-threatening disorders.

Moreover, huge investments in the biotech and pharmaceutical industries for high-throughput screening technology in terms of miniaturization, automation, and assay methodology have helped spur market growth globally. Additionally, the end-users of the HTS market have perceived a growing number of clinical candidates and marketed drugs arising from the advanced techniques utilized.

High demand, new product launches, and the presence of top players hold North America in a dominant position.

At present, North America (dominantly the U.S.) generates the maximum market share in the global market, thanks to new product launches and advanced automation techniques. Convenient access to HTS laboratories facilitating advanced assay technologies for performing primary and secondary screening campaigns is on the rise in the U.S.

Other prominent factors leading the market’s growth include the demand for extensive automation techniques in HTS, increased research and development activities on toxicology and stem cells, and the integration of advanced data management and information systems. However, high costs, limited availability of automated systems, a lack of trained staff, and complexity in assay development and techniques are limiting the growth of the HTS market.

The dominance of multinational manufacturers with strong product portfolios in the developed regions

Major players in the high-throughput screening market are Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories; Agilent Technologies, Inc.; Tecan Group Ltd.; Aurora Biomed; Perkinelmer, Inc.; Sigma Aldrich Corporation; Axxam Spa; Hamilton Company; Aurora Biomed, Inc.; Danaher Corporation; Beckman Coulter, Inc.; GE Healthcare; and others. Top companies are producing high-throughput screening in a highly automated environment. Additionally, partnerships with other companies, research organizations, and academic institutes will further drive the market’s growth.

For instance, in February 2018, Charles River Laboratories declared a new agreement that grants commercial access to AstraZeneca’s high-throughput screening systems and compound management infrastructure. The company will perform high-throughput screening programs by utilizing AstraZeneca’s hi-tech HTS facility.

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report also encompasses qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better understanding of the overall high-throughput screening market. Additionally, the report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key questions are answered in this report.

What are the current and future trends in high-throughput screening?
What are the current dynamics in automated systems, as well as the valuable opportunities for new entrants?
Which application segment accounts for the fastest CAGR during the forecast period?
Which end-user type holds a larger market share and why?
What is the impact of the high cost of automated systems in the high-throughput screening market?
What are the products and brands in the HTS industry that are growing most significantly, and why?
What is the impact of information systems on the global market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and the Middle East and Africa?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global HTS Market Portraiture
2.2. Global HTS Market, by Technology Type, 2017 (US$ Bn)
2.3. Global HTS Market, by Application, 2017 (US$ Bn)
2.4. Global HTS Market, by End User, 2017 (US$ Bn)
2.5. Global HTS Market, by Geography, 2017US$ Bn)

Chapter 3. Global High Throughput Screening (HTS) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. HTS Market Technologies: Future Trends
3.3. Drivers
3.3.1. Driver 1
3.3.2. Driver 2
3.4. Challenges
3.4.1. Challenge 1
3.4.2. Challenge 2
3.5. Opportunities
3.5.1. Opportunity 1
3.5.2. Opportunity 2
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global High Throughput Screening (HTS) Market, by Technology Type, 2016 – 2026 (US$ Bn)
4.1. Overview
4.2. Cell Based Assays
4.3. Ultra High Throughput Screening
4.4. Lab-on-a-Chip
4.5. Bioinformatics
4.6. Label Free Technology

Chapter 5. Global High Throughput Screening (HTS) Market, by Application, 2016 – 2026 (US$)
5.1. Overview
5.2. Target Identification
5.3. Primary & Secondary Screening
5.4. Toxicology Assessment
5.5. Others

Chapter 6. Global High Throughput Screening (HTS) Market, by End User, 2016 – 2026 (US$)
6.1. Overview
6.2. Biotechnology & Pharmaceutical Industries
6.3. Academic & Government Research Institutes
6.4. Contract Research Organizations
6.5. Others

Chapter 7. Global High Throughput Screening (HTS) Market, by Geography, 2016 – 2026 (US$ Bn)
7.1. Overview
7.2. North America HTS Market Analysis, 2016 – 2026
7.2.1. North America HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.2.2. North America HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.2.3. North America HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.2.4. North America HTS Market, by Country, 2016 – 2026 (US$ Bn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe HTS Market Analysis, 2016 – 2026
7.3.1. Europe HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.3.2. Europe HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.3.3. Europe HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.3.4. Europe HTS Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific HTS Market Analysis, 2016 – 2026
7.4.1. Asia Pacific HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.4.2. Asia Pacific HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.4.3. Asia Pacific HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.4.4. Asia Pacific HTS Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America HTS Market Analysis, 2016 – 2026
7.5.1. Latin America HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.5.2. Latin America HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.5.3. Latin America HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.5.4. Latin America HTS Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) HTS Market Analysis, 2016 – 2026
7.6.1. MEA HTS Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.6.2. MEA HTS Market, by Application, 2016 – 2026 (US$ Bn)
7.6.3. MEA HTS Market, by End User, 2016 – 2026 (US$ Bn)
7.6.4. MEA HTS Market, by Region, 2016 – 2026 (US$ Bn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Thermo Fisher Scientific, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Bio-Rad Laboratories
8.3. Agilent Technologies, Inc.
8.4. Tecan Group Ltd.
8.5. Aurora Biomed
8.6. Perkinelmer, Inc.
8.7. Sigma Aldrich Corporation
8.8. Axxam Spa
8.9. Hamilton Company
8.10. Aurora Biomed, Inc.
8.11. Danaher Corporation
8.12. GE Healthcare

List of Figures

FIG. 1 Global High Throughput Screening (HTS) Market Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global HTS Market Segmentation
FIG. 4 Global HTS Market, by Technology Type, 2017 (US$ Bn)
FIG. 5 Global HTS Market, by Application, 2017 (US$ Bn)
FIG. 6 Global HTS Market, by End User, 2017 (US$ Bn)
FIG. 7 Global HTS Market, by Geography, 2017 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Global Market Positioning of Key High Throughput Screening Solutions Manufacturers, 2017
FIG. 10 Global Cell Based Assays for HTS Market, 2016–2026 (US$ Bn)
FIG. 11 Global Ultra HTS Market, 2016–2026 (US$ Bn)
FIG. 12 Global Lab-on-a-Chip for HTS Market, 2016–2026 (US$ Bn)
FIG. 13 Global Bioinformatics for HTS Market, 2016–2026 (US$ Bn)
FIG. 14 Global Label Free Technology for HTS Market, 2016–2026 (US$ Bn)
FIG. 15 Global Drug Discovery Platforms Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 16 Global Primary & Secondary Screening Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 17 Global Toxicology Assessment Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 18 Global Other Applications for HTS Market, 2016–2026 (US$ Bn)
FIG. 19 Global HTS Market in Biotech & Pharma Industries, 2016–2026 (US$ Bn)
FIG. 20 Global HTS Market in Academic & Government Research Institutes, 2016–2026 (US$ Bn)
FIG. 21 Global HTS Market in Contract Research Organizations, 2016–2026 (US$ Bn)
FIG. 22 Global HTS Market in Other End-Users, 2016–2026 (US$ Bn)
FIG. 23 U.S. HTS Market, 2016–2026 (US$ Bn)
FIG. 24 Canada HTS Market, 2016–2026 (US$ Bn)
FIG. 25 U.K. HTS Market, 2016–2026 (US$ Bn)
FIG. 26 Germany HTS Market, 2016–2026 (US$ Bn)
FIG. 27 Rest of Europe HTS Market, 2016–2026 (US$ Bn)
FIG. 28 Japan HTS Market, 2016–2026 (US$ Bn)
FIG. 29 China HTS Market, 2016–2026 (US$ Bn)
FIG. 30 Rest of Asia Pacific HTS Market, 2016–2026 (US$ Bn)
FIG. 31 Brazil HTS Market, 2016–2026 (US$ Bn)
FIG. 32 Mexico HTS Market, 2016–2026 (US$ Bn)
FIG. 33 Rest of Latin America HTS Market, 2016–2026 (US$ Bn)
FIG. 34 GCC HTS Market, 2016–2026 (US$ Bn)
FIG. 35 Rest of Middle East & Africa HTS Market, 2016–2026 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global High Throughput Screening (HTS) Market
TABLE 2 Global HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 3 Global HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 4 Global HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 5 Global HTS Market, by Geography, 2016–2026 (US$ Bn)
TABLE 6 North America HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 7 North America HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 8 North America HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 9 North America HTS Market, by Country, 2016–2026 (US$ Bn)
TABLE 10 Europe HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 11 Europe HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 12 Europe HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 13 Europe HTS Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 14 Latin America HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 15 Latin America HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 16 Latin America HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 17 Latin America HTS Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 18 Asia Pacific HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 19 Asia Pacific HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 20 Asia Pacific HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 21 Asia Pacific HTS Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 22 Middle East & Africa HTS Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 23 Middle East & Africa HTS Market, by Application, 2016–2026 (US$ Bn)
TABLE 24 Middle East & Africa HTS Market, by End User, 2016–2026 (US$ Bn)
TABLE 25 Middle East & Africa HTS Market, by Region, 2016–2026 (US$ Bn)
TABLE 26 Thermo Fisher Scientific: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Bio-Rad Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Agilent Technologies, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Tecan Group Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Aurora Biomed: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 PerkinElmer, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 GE Healthcare: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Sigma Aldrich Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Axxam Spa: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 35 Hamilton Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 36 Aurora Biomed, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 37 Danaher Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

Frequently Asked Question

What is the size of High Throughput Screening Market?

The market for High Throughput Screening Market is expected to reach USD$ 24.4 Bn in 2026.

What is the High Throughput Screening Market CAGR?

The High Throughput Screening Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for High Throughput Screening Market?

The report is forecasted from 2018 -2026.

What is the base year considered for High Throughput Screening Market?

The base year of this report is 2017.

Who are the major players in this market?

Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories; Agilent Technologies, Inc.; Tecan Group Ltd.; Aurora Biomed; Perkinelmer, Inc.; Sigma Aldrich Corporation. are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –